Yu Qin

816 total citations
42 papers, 440 citations indexed

About

Yu Qin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yu Qin has authored 42 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Yu Qin's work include Cancer Immunotherapy and Biomarkers (6 papers), Multiple Myeloma Research and Treatments (5 papers) and MicroRNA in disease regulation (4 papers). Yu Qin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Multiple Myeloma Research and Treatments (5 papers) and MicroRNA in disease regulation (4 papers). Yu Qin collaborates with scholars based in China, United States and Canada. Yu Qin's co-authors include Peter Wang, Xishan Hao, Huikai Li, Qiang Li, Zhi Yang, Michel Champagne, Shaoyun Guo, Richard Gendron, Jiabin Shen and Yan Xu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The FASEB Journal.

In The Last Decade

Yu Qin

38 papers receiving 434 citations

Peers

Countries citing papers authored by Yu Qin

Since Specialization

Citations

This map shows the geographic impact of Yu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Qin more than expected).

Fields of papers citing papers by Yu Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Qin. The network helps show where Yu Qin may publish in the future.

Co-authorship network of co-authors of Yu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Qin. A scholar is included among the top collaborators of Yu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Qin. Yu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experimental research on fracture initiation and propagation behavior in argillaceous silt hydrate reservoirs 2025 ·Geoenergy Science and Engineering ·(unknown), Yiqun Zhang, (unknown), (unknown), Xiaoying Zhuang, Jinshan Wang, Yu Qin, Gensheng Li	1
2	A one-to-many authentication and key agreement scheme based on the sliding window 2025 ·Yu Qin, Meng Xu, (unknown), (unknown)	0
3	Diterpenoids with unexpected 5/6/6-fused ring system and its dimer from Strophioblachia glandulosa 2024 ·Chinese Chemical Letters ·Xue Wu, (unknown), Yu Qin, Yongxiang Huang, Muhammad Aurang Zeb, Bin Cheng, Xiaoli Li, Chang‐Bo Zheng, Wei‐Lie Xiao	1
4	Functionalizing Sgc8‐Paclitaxel Conjugates with F‐Base Modifications: Targeted Drug Delivery with Optimized Cardiac Safety 2024 ·ChemMedChem ·(unknown), (unknown), (unknown), (unknown), Yu Qin, Ancai Yuan, Ruowen Wang, Yuquan Xie, Jun Pu, (unknown)	2
5	AB0988 GENETIC EVIDENCE FOR A BIDIRECTIONAL CAUSAL RELATIONSHIP BETWEEN ANKYLOSING SPONDYLITIS AND CARDIOVASCULAR DISEASE 2023 ·(unknown), Qi Liang, (unknown), Lili Niu, (unknown), Yu Qin, P. F. He, Xue Li, (unknown)	0
6	Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study 2022 ·Cancer Medicine ·(unknown), Yu Qin, Jing Zhou, Ru Chen, Jianhua Gu, (unknown), Jiachen Zhou, (unknown), Dongmei Lin, Jinwu Wang, Dajun Deng, Wenqiang Wei	8
7	The willingness of Chinese healthcare workers to receive monkeypox vaccine and its independent predictors: A cross‐sectional survey 2022 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xiaojie Yan, (unknown), Yu Qin	32
8	Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis 2022 ·BMC Pediatrics ·(unknown), Lu Han, Linan Zeng, Qianqian Zhang, Shouming Chen, Liang Huang, Zhi‐Jun Jia, Yu Qin, Lingli Zhang	8
9	Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology 2022 ·Journal of Ethnopharmacology ·Yu Qin, Zhe Chen, Ming‐Lin Liu, (unknown), (unknown), Bai Li, Juan Du	3
10	LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway 2021 ·Genes & Genomics ·Hong Li, Yu Wu, Runmei Wang, (unknown), Yu Qin, Lihe Zhang, (unknown), Hao Yang	3
11	Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy 2021 ·Frontiers in Oncology ·Yu Qin, Jing Zhou, (unknown), Jianhua Gu, (unknown), Dongmei Lin, Dajun Deng, Wenqiang Wei	2
12	912MO A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study 2020 ·Annals of Oncology ·(unknown), Yun Yang, (unknown), (unknown), Jianji Pan, (unknown), Lizhu Lin, Ying Shi, Weineng Feng, Jianping Xiong, Kunyu Yang, Yu Qin, Desheng Hu, Yan Sun, (unknown), Guoqing Hu, (unknown), (unknown), Qing Yang, (unknown)	5
13	270MO A single-arm, open-label, multicenter phase II study of camrelizumab in patients with recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC) who had progressed on ≥2 lines of chemotherapy: CAPTAIN study 2020 ·Annals of Oncology ·(unknown), Yun Yang, (unknown), (unknown), Jianji Pan, (unknown), Lizhu Lin, Ying Shi, Weineng Feng, Jianping Xiong, Kunyu Yang, Yu Qin, Desheng Hu, Yan Sun, (unknown), Guoqing Hu, (unknown), (unknown), Qing Yang, (unknown)	1
14	ID:1329 ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC 2020 ·Journal of Thoracic Oncology ·L. Zhang, Yunpeng Yang, Zhaoguang Wang, Jian Fang, Yu Qin, Bei Han, Shundong Cang, G. Chen, Xiaodong Mei, Zhixiong Yang, Rui Ma, (unknown), Xiubao Ren, Jianying Zhou, (unknown), Wanhai Xu, Yinghua Ji, Bo Peng	4
15	Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study 2016 ·Lung Cancer ·Lin Zhou, (unknown), (unknown), Yongmei Liu, (unknown), Yu Qin, Maozhi Liang, Xiaojuan Zhou, Zhenyu Ding, Meijuan Huang, Li Ren, Jiang Zhu, Lu Li, Mei Hou, Lieming Ding, Fenlai Tan, You Lü	26
16	Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma 2015 ·Leukemia Research ·Fei Li, Mu Hao, Xiaoyan Feng, Meirong Zang, Yu Qin, Shuhua Yi, Zengjun Li, Yan Xu, Lili Zhou, Weiwei Sui, Shuhui Deng, Dehui Zou, Fenghuang Zhan, Lugui Qiu	22
17	[Application of European five-dimensional health questionnaire for the quality of life among the population over 60 years old in Dalian city]. 2014 ·PubMed ·Yu Qin, Hairui Zhang, (unknown), Li Ma, Junfeng Chen	1
18	Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma 2012 ·Annals of Oncology ·Chunyan Xue, Yingying Huang, Pei Huang, Yu Qin, Jianji Pan, Longzhong Liu, (unknown), (unknown), Jun Wu, (unknown), Hong Zhao, Fei Xu, (unknown), Zhanying Hu, Li Zhao, Yuanyuan Zhao, Xuan Wu, (unknown), (unknown), (unknown)	58
19	Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A Chinese experience 2006 ·Journal of Gastroenterology and Hepatology ·Qiang Li, Huikai Li, Yu Qin, Peter Wang, Xishan Hao	51
20	The Effect of KLT(KangLaiTe)on Immune Function in Patients with Advanced Primary Hepatocarcinoma 2001 ·Yu Qin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact